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Mycobacterium tuberculosis promotes its replication
by inhibiting the apoptosis of infected macrophages.
A proapoptoticM. tuberculosismutant lacking nuoG,
a subunit of the type I NADH dehydrogenase
complex, exhibits attenuated growth in vivo, indi-
cating that this virulence mechanism is essential.
We show that M. tuberculosis also suppresses
neutrophil apoptosis. Compared to wild-type, the
nuoG mutant spread to a larger number of lung
phagocytic cells. Consistent with the shorter lifespan
of infected neutrophils, infection with the nuoG
mutant resulted in fewer bacteria per infected
neutrophil, accelerated bacterial acquisition by
dendritic cells, earlier trafficking of these dendritic
cells to lymph nodes, and faster CD4 T cell priming.
Neutrophil depletion abrogated accelerated CD4
T cell priming by the nuoG mutant, suggesting that
inhibiting neutrophil apoptosis delays adaptive
immunity in tuberculosis. Thus, pathogen modula-
tion of apoptosis is beneficial at multiple levels, and
enhancing phagocyte apoptosis promotes CD4 as
well as CD8 T cell responses.
INTRODUCTION
M. tuberculosis possesses multiple strategies to avoid elimina-
tion by immune responses. Among these is modulation of host
cell apoptosis (Behar et al., 2010; Briken and Miller, 2008;
Porcelli and Jacobs, 2008). Although isolated components of
M. tuberculosis have been shown to induce macrophage
apoptosis (Dao et al., 2004; Derrick and Morris, 2007; Lo´pez
et al., 2003; Persson et al., 2009), live virulent strains of
M. tuberculosis also possess antiapoptotic mechanisms (Behar
et al., 2010; Briken and Miller, 2008; Porcelli and Jacobs, 2008).Cell HThese presently include the inhibition of reactive oxygen
species-dependent apoptosis (Miller et al., 2010), downregula-
tion of surface expression of Fas (Oddo et al., 1998), interference
with autocrine/paracrine TNF-a signaling (Balcewicz-Sablinska
et al., 1998), induction of lipoxin A4, which alters TNF expression
and promotes cellular necrosis rather than apoptosis (Chen
et al., 2008; Divangahi et al., 2010; Tobin et al., 2010), increasing
expression of the antiapoptotic protein Mcl-1 (Sly et al., 2003),
and interference with formation of the apoptotic envelope (Gan
et al., 2008).
A role for apoptosis as an antimycobacterial mechanism
was initially discovered in cultured primary human alveolar
macrophages, where attenuated mycobacterial strains
(M. tuberculosis H37Ra,M. bovis BCG, andM. kansaii) exhibited
reduced viability as their host macrophages underwent
apoptosis, whereas virulent strains of M. tuberculosis provoked
little or no apoptosis and exhibited progressive intracellular
growth in cultured macrophages (Keane et al., 2000). In vivo
validation of apoptosis inhibition as a virulence mechanism
has been provided by the attenuated phenotype of the
M. tuberculosis proapoptotic secA2 and nuoG deletion mutants
(Hinchey et al., 2007; Velmurugan et al., 2007). M. tuberculosis
nuoG encodes a subunit of the type I NADH dehydrogenase
complex, which is necessary for suppression of reactive oxygen
species formed by the host macrophage NOX2 complex and,
thus, inhibits TNF-mediated apoptosis induction (Miller et al.,
2010).
Because innate immune mechanisms are insufficient to con-
trol progressive infection, effective immunity to M. tuberculosis
requires CD4 Th1 and CD8 T lymphocyte responses to
M. tuberculosis antigens (Gallegos et al., 2008; Hoang et al.,
2009; Mogues et al., 2001; Woodworth and Behar, 2006). The
adaptive immune response and initial activation of naive CD4
cells in the lung-draining lymph node depends on dendritic cells
(DC) (Khader et al., 2006; Tian et al., 2005; Wolf et al., 2008),
which not only acquire bacterial antigens for presentation
through direct uptake of bacteria but also through uptake of
infected and dying cells. DC can acquire antigens through
uptake of macrophage-derived apoptotic vesicles (Schaibleost & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Inc. 81
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(Clayton et al., 2003). We recently found that DC that acquire
bacteria by ingesting infected neutrophils are as efficient at
inducing proliferation and activation of M. tuberculosis-specific
CD4 T cells as DC that contained bacteria acquired by direct
infection in vitro and in vivo. We additionally found that DC
that acquire M. tuberculosis through ingestion of infected
neutrophils are superior in migrating toward lymph node chemo-
kines when compared to directly-infected DC (Blomgran and
Ernst, 2011).
Although much of the effort to understand apoptosis and
immunity toM. tuberculosis has concentrated on macrophages,
other myeloid cell subsets also contribute to tuberculosis immu-
nity. Neutrophils are a subset of polymorphonuclear leukocytes
(PMN), which are highly mobile phagocytes that contribute to
early defense against microbial pathogens and readily undergo
apoptosis followed by ingestion and disposal by longer-lived
professional phagocytes such as macrophages and dendritic
cells (Serhan and Savill, 2005). Neutrophils have been implicated
in immunity toM. tuberculosis through several avenues of inves-
tigation. Human neutrophil-derived peptides restrict growth or
kill M. tuberculosis (Martineau et al., 2007), and macrophages
can acquire neutrophil defensins to contribute to innate defense
against mycobacterial infections (Silva et al., 1989). Moreover,
the risk of tuberculosis infection among household contacts
has been found to be inversely associated with peripheral blood
neutrophil count (Martineau et al., 2007), and a neutrophil-driven
transcriptional signature is prominent in the blood of tuberculosis
patients (Berry et al., 2010).
Here, using low dose aerosol infection with a proapoptotic
nuoG-deficient mutant strain of M. tuberculosis (Miller et al.,
2010; Velmurugan et al., 2007) compared with M. tuberculosis
H37Rv, we found that M. tuberculosis suppresses apoptosis of
neutrophils in vivo, resulting in restricted distribution and spread
of bacteria within and between lung-cell subsets. This in turn
hinders timely acquisition of bacteria by myeloid dendritic cells
and delays activation and proliferation of naive M. tuberculosis
Ag85B-specific CD4 T cells in the mediastinal lymph node.
These results indicate that M. tuberculosis modulation of
neutrophil apoptosis is an additional mechanism of virulence
that alters the kinetics of development of adaptive immunity
and contributes to the ability of the bacteria to establish persis-
tent infection.
RESULTS
Increased Caspase-3 Activation by DnuoG Mutant
M. tuberculosis
Although the virulence of M. tuberculosis has been linked to its
ability to inhibit macrophage apoptosis, it is not clear whether
the antiapoptotic mechanisms of M. tuberculosis are also em-
ployed in other myeloid cells during in vivo infection. Whereas
we have previously found that M. tuberculosis resides in a
broad range of myeloid cells in the lungs, including neutrophils,
alveolar and recruited macrophages, monocytes, and migratory
dendritic cells (Wolf et al., 2007), we considered the possibility
that one or more of these myeloid cell subsets, other than
macrophages, might also be targeted by the antiapoptotic
activities of M. tuberculosis in order to provide the bacteria82 Cell Host & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Ia range of optimal cellular niches. Because activation by proteo-
lytic cleavage of caspase 3 is central to multiple apoptotic path-
ways, we identified apoptotic cells by staining permeabilized
cells with an antibody that specifically detects the cleaved/
activated form of caspase 3. When coupled with staining of
specific surface markers and flow cytometry, this allowed us to
compare the frequency of apoptosis in previously defined
myeloid cell subsets after aerosol infection of mice with either
wild-type M. tuberculosis H37Rv or a well-characterized proap-
optotic strain of M. tuberculosis H37Rv, which lacks the nuoG
gene (subsequently termed wild-type and DnuoG, respectively.
Because the spectrum of M. tuberculosis-infected cells in the
lungs is broadest during the third week of infection (Wolf et al.,
2007), we focused on this stage of infection.
At the earliest time point examined (day 14 postinfection),
fewer than 1% of the alveolar macrophages, neutrophils, or
myeloid DCs exhibited staining for cleaved caspase 3 (CC3+)
in mice infected with either the wild-type or the DnuoG strain
of M. tuberculosis (Figure 1A available online). At the same
time point, a higher frequency (2%–3%) of the recruited macro-
phages and monocytes were CC3+, although there was no
significant difference in the frequency of apoptotic cells in these
subsets in samples from mice infected with the wild-type or
DnuoG strains. After day 14 postinfection, three patterns were
apparent. In neutrophils and DC, the number of apoptotic cells
in each subset increased progressively on days 15 and 17 com-
pared with that on day 14; the number of apoptotic neutrophils
and DC were significantly greater in the lungs of mice infected
with the DnuoG strain compared with the wild-type strain, indi-
cating that the antiapoptotic activity of nuoG is operative in
neutrophils and DC at this stage of infection (Figure 1A). In
contrast, in the recruited macrophages and monocytes, the
number of CC3+ apoptotic cells fluctuated in a narrow range
on days 14, 15, and 17 in mice infected with wild-type bacteria.
In two independent experiments, we observed that the number
of CC3+ cells in these cell subsets was lower on day 15 than
on either day 14 or 17 in mice infected with wild-type bacteria.
By comparison, the number of CC3+ cells was slightly but signif-
icantly higher in the recruited macrophage and monocyte
subsets on days 15 and 17 in mice infected with the DnuoG
strain. These results provide direct in vivo confirmation of the
observations using cultured cells that the product of the nuoG
gene acts to inhibit macrophage apoptosis. The third pattern
of apoptosis in cells of mice infected with wild-type
M. tuberculosis was observed only in alveolar macrophages,
which exhibited little variation in the number of CC3+ cells on
days 14–17. In mice infected with the DnuoG strain, the number
of CC3+ alveolar macrophages peaked on day 15, followed by
a decrease on day 17 (Figure 1A). On day 15, differences in
CC3+ cell numbers reflected differences in total cell numbers
for each lung-cell subset in mice infected with the wild-type or
DnuoG strains; this resemblance was not observed on day 17
when, with the exception of DCs, there were no significant
differences in the number of cells of each subset in the two
groups of infected mice (Figure S1). The differences in the
number of apoptotic cells in the lungs were not attributable to
a difference in the number of bacteria in the lungs because the
bacterial burdens in wild-type H37Rv- and DnuoG-infected
mice were indistinguishable on days 14, 15, and 17 postinfectionnc.
Figure 1. Increased Frequency of Apoptosis of Diverse Myeloid Cells in Lungs of Mice Infected with DnuoG M. tuberculosis
(A) Single-cell preparations from lungs of C57BL/6Jmice infected with wild-type H37Rv orDnuoGM. tuberculosiswere identified as neutrophils (Gr-1hi/CD11bhi),
myeloid dendritic cells (CD11bhi/CD11chi), alveolar macrophages (CD11blow/CD11chi), recruited macrophages (CD11bhi/CD11cintermediate), or monocytes
(CD11bhi/CD11cneg). After surface staining, fixation, and permeabilization, cells were stained for the presence of activated caspase-3. Cell numbers were
calculated by multiplying the percentage in each subset obtained through flow cytometry by the total number of cells determined through manual count of the
total number of cells from each mouse.
(B) Growth of bacteria in the lungs after aerosol infection with the DnuoG and wild-type H37Rv strains of M. tuberculosis. There were no statistically significant
differences in the number of bacteria of the two strains at any time point examined. Data in A and B aremean ± SD of fivemice per group and time point, and each
represent data from two separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S1.
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mutant wasmanifest in cells that contained bacteria, as detected
using flow cytometry with GFP-expressing strains of
M. tuberculosis (Figure S2), a higher frequency of apoptosis
was also observed in cells that did not contain detectable
bacteria when isolated from the lungs of DnuoG-infected mice
(Table S1).
These results confirm that the antiapoptotic activity of
M. tuberculosis nuoG is detectable in cells isolated from the
lungs of infected mice. Moreover, they indicate that the antia-
poptotic activity of M. tuberculosis nuoG is not restricted to
macrophages and affects multiple myeloid cell subsets,
including lung neutrophils and dendritic cells, during the earlyCell Hstage of infection. They also indicate that enhanced apoptosis
at the time points examined did not have a detectable effect
on the overall bacterial growth in the lungs.
Effect of Enhanced Apoptosis on the Cellular
Distribution ofM. tuberculosis
Because we found an increase in the number of apoptotic cells
in diverse myeloid cell subsets in the lungs after infection
withDnuoG comparedwithwild-type H37Rvwithout a difference
in the bacterial population size during the initial 3weeks of
infection, we examined the postinfection cellular distribution of
M. tuberculosis with green fluorescent protein (GFP)-expressing
bacteria of both strains. Although kinetics and extent of infectionost & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Inc. 83
Figure 2. The Proapoptotic DnuoG Mutant Is Present in a Larger Number of Diverse Lung Myeloid Cells In Vivo
C57BL/6J mice were infected with GFP-expressing wild-type H37Rv or DnuoG M. tuberculosis as in Figure 1, and the total number of infected cells in each
myeloid-cell subset was analyzed using flow cytometry detection of cells containing GFP-expressing bacteria. Data shown are mean ± SD of five mice per group
and time point, and represent data from two separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2 and Table S1.
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numbers in each phagocytic-cell subset in the lungs compared
to H37Rv on days 14, 15, and 17 postinfection (Figure 2). This
implies that the enhanced apoptosis of cells infected with the
DnuoG strain is associated with release of bacteria from dying
cells and subsequent uptake by additional phagocytic cells
present in the lungs. The striking increase in infected (GFP+)
and apoptotic (CC3+) neutrophils between days 14 and 15
mirrored the increase in the total number of neutrophils that
occurred at that time (Figure S1), consistent with an especially
active flux of neutrophils and bacteria at this stage of the
infection.
Lung Myeloid Cells of DnuoG-Infected Mice Contain
Fewer Bacteria per Infected Cell
The finding of larger numbers of infected cells in mice infected
with the proapoptotic DnuoG mutant compared with H37Rv, in
the absence of a difference in total bacterial burdens,
suggests that there must be a difference in the number of
bacteria per infected cell. To examine this possibility, we
sorted cells on the basis of their surface phenotypes and pres-
ence of GFP-expressing bacteria and then manually counted
the number of bacteria per infected cell using fluorescence
microscopy. Compared with H37Rv, this revealed that there
were fewer DnuoG bacteria per infected cell. Neutrophils,
dendritic cells, and alveolar macrophages showed a higher
frequency of cells containing one bacterium per infected cell
and fewer that contained R 8 bacteria per infected cell (Fig-
ure 3). A similar pattern was observed in the recruited macro-
phage subset but it was not statistically significant. These
results indicate that, by inhibiting apoptosis of diverse phago-84 Cell Host & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Icytic cells in vivo, wild-type M. tuberculosis achieves higher
bacterial burdens per cell, most likely by promoting longer
survival of the host cell so that it can support intracellular
bacterial replication.
Deletion of nuoG Accelerates Transport of
M. tuberculosis to the Lung-Draining Lymph Node and
Accelerates Activation of Antigen-Specific CD4 T Cells
Because the proapoptic DnuoG mutant is acquired by lung
dendritic cells earlier in the course of infection compared
with H37Rv (Figure 2), and because dendritic cells transport
M. tuberculosis from the lungs to the mediastinal lymph
node (Wolf et al., 2008), we determined whether this resulted
in earlier trafficking of the DnuoG mutant to the mediastinal
lymph node. Despite the absence of a difference in the lung
bacterial burdens, there were 3- to 8-fold more DnuoG than
H37Rv CFU in the mediastinal lymph node at day 14 postin-
fection (Figure 4). This indicates that, by inhibiting apoptosis
of the lung cells it infects, M. tuberculosis delays its transport
to the local lymph node. Because initial proliferation of
M. tuberculosis antigen-specific naive CD4 T cells occurs in
the mediastinal lymph node requiring transport of live bacteria
from the lungs to the lymph node by dendritic cells, we deter-
mined whether the earlier appearance of the DnuoG mutant in
the lymph node resulted in earlier activation of the adaptive
immune response. To examine this possibility, we adoptively
transferred CFSE-labeled naive M. tuberculosis antigen 85B
peptide 25-specific TCR transgenic (P25TCR-Tg) CD4 T
(CD45.2) cells into C57BL/6 (CD45.1) mice one day prior to
infection. We found that 14 days postinfection P25TCR-Tg
T cells in the lung-draining lymph nodes of DnuoG-infectednc.
Figure 3. The Proapoptotic DnuoG Mutant is Present as Fewer Bacteria per Infected Cell than Wild-Type H37Rv
C57BL/6Jmice were infected with GFP-expressing wild-type H37Rv orDnuoGM. tuberculosis. GFP+ neutrophils, myeloid dendritic cells, alveolar macrophages,
and recruitedmacrophages were sorted by FACS on day 17 postinfection. Lung cells from threemicewere pooled prior to sorting, and three pools per groupwere
analyzed to ensure that 200–400 infected cells per pool could be examined by fluorescent microscopy. Cells containing 8 or more bacteria/cell are designated as
8+. Insufficient numbers of infectedmonocytes were obtained for analysis. Data aremean ± SD from ninemice per group analyzed in pools of threemice per pool.
*p < 0.05; **p < 0.01; ***p < 0.001.
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frequency of that in mice infected with H37Rv (Figure 5A).
Likewise, when we analyzed proliferation of naive P25TCR-
Tg CD4 T cells in the lymph node, we found that they were
activated to proliferate earlier in mice infected with DnuoG
than in mice infected with H37Rv: on day 14 postinfection,
the percentage of P25TCR-Tg CD4 T cells that had undergone
at least one cycle of proliferation was 3.6-fold higher in mice
infected with DnuoG and proliferation in mice infected with
H37Rv was equivalent to that in mice infected with DnuoG
by day 17 (Figures 5B and 5C). This supports a model in which
the accelerated acquisition of M. tuberculosis DnuoG by lung
dendritic cells and the accelerated transport of DnuoG to the
mediastinal lymph node are associated with earlier activation
of naive antigen-specific CD4 T cells. These data also indicate
that inhibition of apoptosis by wild-type M. tuberculosis
contributes to the delayed activation of antigen-specific CD4
T cells in vivo.
Enhanced Neutrophil Apoptosis Contributes
to Accelerated Proliferation of M. tuberculosis
Ag85B-Specific CD4 T Cells
The evidence that DnuoG enhanced apoptosis of diverse
subsets of phagocytic cells in the lungs, including neutrophils,
together with the finding that DnuoG is associated withCell Henhanced trafficking of bacteria to the mediastinal lymph
node and with earlier activation of naive antigen-specific CD4
T cells, led us to hypothesize that enhanced apoptosis of
neutrophils may contribute to these phenomena in
M. tuberculosis infection. To test this hypothesis, we depleted
neutrophils from mice infected with the DnuoG mutant on day
8 postinfection and quantitated the bacteria and proliferation
of naive P25TCR-Tg CD4 T cells in the mediastinal lymph
node on day 14 postinfection (Figures 5D and 5E). Similar to
our observations in earlier experiments (Figure 4), there were
10.8-fold more bacteria in the mediastinal lymph nodes of
mice infected with the DnuoG mutant than H37Rv; > 70% of
this difference was abrogated by neutrophil depletion using
the 1A8 antibody (Figure 5D). Likewise, as observed in other
experiments (Figures 5A–5C), the frequency of proliferation in
naive P25TCR-Tg CD4+ T cells was > 3-fold higher at this
time point in mice infected with the DnuoG mutant than in
mice infected with H37Rv; 64% of this difference was abro-
gated by specific depletion of neutrophils (Figure 5E). Therefore,
we conclude that the accelerated activation of naive antigen-
specific CD4 T cells in DnuoG-infected mice is due in part to
accelerated neutrophil apoptosis; thus, inhibition of neutrophil
apoptosis by wild-type virulent M. tuberculosis contributes to
the delayed activation of naive CD4 T cells that is characteristic
of tuberculosis.ost & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Inc. 85
Figure 4. The Proapoptotic DnuoG Mutant Traffics to the Medias-
tinal Lymph Node Earlier than Wild-Type H37Rv
C57BL/6 J mice were infected with wild-type H37Rv or DnuoG and the
bacterial burden in the mediastinal lymph node was determined on the
designated days postinfection. Data in experiment 1 are from the same
experiment as displayed in Figures 1, 2, and 5A–5C). * designates p < 0.05.
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The results reported here reveal insight into several aspects of
pathogenesis and immunity in tuberculosis. First, by staining
permeabilized cells with an antibody to activated caspase 3
and analysis by flow cytometry, combined with infection of
mice with a proapoptotic (DnuoG) mutant ofM. tuberculosis, we
found that wild-type virulent M. tuberculosis inhibits apoptosis
of diverse lung phagocytes, including neutrophils and dendritic
cells, in addition to macrophages. These findings indicate that
further investigation and characterization of apoptosis in cells
other than macrophages offers the opportunity to significantly
expand the current understanding of tuberculosis pathogenesis
and immunity. Theyalsosupport andextend thepreviousfindings
on two proapoptotic M. tuberculosis mutants that had been
characterized mainly using in vitro assays with bone-marrow
derived murine macrophages and the human macrophage cell
line, THP-1 (Hinchey et al., 2007; Velmurugan et al., 2007) or
primary human alveolar macrophages (Miller et al., 2010).
Second, we found that inhibition of apoptosis by
M. tuberculosis apparently limits cell-to-cell spread of the
bacteria in the lungs at the stage of infection immediately
preceding the onset of activation of naive antigen-specific CD4
T cells. In this context, restricted cell-to-cell spread was mani-
fest by a smaller number of M. tuberculosis-infected cells in
the lungs and by a larger number of bacteria per infected phago-
cytic cell, without a difference in the overall size of the bacterial
population in the lungs. The differential distribution of the proap-
optotic DnuoG mutant, which was found in a larger number of
cells than its wild-type counterpart, was associated with
increased acquisition of M. tuberculosis by dendritic cells in
the lungs, by accelerated dendritic cell transport of bacteria to
the mediastinal lymph node and by accelerated activation of
naiveM. tuberculosis antigen-specific CD4 T cells. These results
indicate that a large fraction of the bacteria released from
apoptotic cells are viable at the time they are taken up by other
phagocytic cells. This contrasts with the findings in studies using86 Cell Host & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Icultured murine and human macrophages, in which apoptosis
has been found to be associated with decreased viability of
the bacteria (Divangahi et al., 2009; Pan et al., 2005; Sly et al.,
2003). Taken together, the data suggest that loss of viability is
not a uniform outcome when M. tuberculosis-infected cells
undergo apoptosis; the fate of the bacteria may depend on the
phenotype and state of activation of the cell, the stage of infec-
tion, and the metabolic or functional state of the bacteria. In this
context, it is notable that the proapoptotic DnuoG mutant is
attenuated in mice during later stages of infection (Velmurugan
et al., 2007), a finding that is consistent with results in congenic
mice that differ at the sst1 locus, in which the allele that causes
a higher frequency of apoptosis is associated with improved
control of bacterial growth late (12 weeks) but not early (3 weeks)
after infection with M. tuberculosis (Pan et al., 2005). Thus,
inhibition of apoptosis appears to have a greater impact
during the adaptive rather than the innate immune phase of
M. tuberculosis infection.
The results reported here are consistent with the prior report
that apoptosis of infected cells promotes cell-to-cell spread of
virulent M. marinum in piscine tuberculosis (Davis and Ramak-
rishnan, 2009). They also indicate that, at distinct stages of
the life cycle of tuberculosis, cell-to-cell spread of the bacteria
may be advantageous to the bacteria or to the host. At the
earliest stage of infection, as in the real-time studies of
M. marinum, cell-to-cell spread promotes expansion of the
bacterial population, which is clearly advantageous to the
bacteria (Davis and Ramakrishnan, 2009). Similar to the studies
reported here, cell-to-cell spread of M. tuberculosis to dendritic
cells in the lungs later in infection, following recruitment of a large
number of dendritic cells to the lungs (which is first detectable
approximately 14 days postinfection [Wolf et al., 2007]),favors
the host. This is a necessary prerequisite for activation of naive
antigen-specific CD4 T cells, whose responses are essential
for immune control of the infection. These apparently disparate
effects indicate that there may be temporal control of apoptosis
byM. tuberculosis in vivo that allows for optimal growth, survival,
and transmission of the bacteria at distinct stages of infection.
Cross-presentation of extracellular antigens by dendritic cells
and subsequent cross-priming of CD8 T cells is an important
immunological mechanism to mount efficient cytolytic T cell
responses (Kurts et al., 2010). Apoptotic bodies containing viral
or bacterial components can induce cross-presentation by DC
(Kurts et al., 2010), especially by the subset of CD11c+
CD11b-CD8a+ DC that is most abundant in the spleen (den
Haan et al., 2000; Dudziak et al., 2007). Consistent with
this, apoptotic vesicles derived from M. tuberculosis-infected
macrophages could mediate crosspriming of CD8 T cells,
leading to improved protection of mice against subsequent
M. tuberculosis infection (Winau et al., 2006). The proapoptotic
M. tuberculosis secA2 mutant expressing the model antigen
ovalbumin induced stronger OVA-specific CD8 T cell responses
(Hinchey et al., 2007). These findings are in line with results
obtained in studies in which intratracheal administration of
M. tuberculosis H37Rv-infected 5-lipoxygenase-deficient
(Alox5/ macrophages, which are more prone to apoptosis,
promoted greater expansion of lung CD8 T cells compared to
that of mice receiving infected macrophages from wild-type
mice (Divangahi et al., 2010). This effect was caspase 8- andnc.
Figure 5. The Proapoptotic DnuoGMutant Is Associated with Earlier Activation of NaiveM. tuberculosis Ag85B-Specific CD4 T Cells In Vivo
Mice were infected one day after adoptive transfer of CFSE-labeled naive P25TCR-Tg CD4+ T cells.
(A) CD4 T cell activation as indicated by CD69 surface expression on P25TCR-Tg cells in the mediastinal lymph node on days 14, 15, and 17 post infection.
(B) Representative CFSE dilution/cell proliferation profiles of adoptively-transferred P25TCR-Tg CD4+ cells in mediastinal lymph nodes of mice infected with
H37Rv or DnuoG, 14 days post infection. The bars indicate the percentage of P25TCR-Tg cells that had undergone one or more cycles of proliferation.
(C) Quantitation of P25TCR-Tg CD4+ T cell proliferation in the mediastinal lymph nodes of groups of mice infected with H37Rv or DnuoG.
(D) Neutrophil depletion abrogates the enhanced trafficking of M. tuberculosis in mice infected with DnuoG. Infected mice treated as in A and B received the
Ly6G-specific neutrophil-depleting antibody 1A8 or isotype control antibody on day 8 postinfection, andM. tuberculosis colony-forming units were quantitated
on day 14 postinfection.
(E) Neutrophil depletion abrogates the accelerated proliferation of Ag85B-specific CD4 T cells in mice infected with DnuoG. P25TCR-Tg CD4+ T cell proliferation
in the mediastinal lymph nodes of the same mice as in D. Data in A–E are mean ± SD of five mice per group and time point, where A–C is representative of three
separate experiments, and D and E of two separate and independent experiments. *p < 0.05; **p < 0.01.
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CD11c+ DC (Divangahi et al., 2010). Interestingly, our studies,
using a proapoptotic mutant strain of bacteria, extend those
findings by demonstrating that increased induction of host-cell
apoptosis not only increases CD8 T cell responses but also
accelerates the onset of M. tuberculosis antigen-specific CD4
T cell responses. In light of efforts to develop more efficacious
tuberculosis vaccines by engineering proapoptotic strains of
BCG, our findings indicate that an additional benefit of those
strains may include enhanced CD4 T cell responses to such
vaccine candidates.
Our present results are also consistent with our recent findings
that lung neutrophils facilitate activation of naive antigen-specific
CD4 T cells in tuberculosis by promoting trafficking of infected
dendritic cells to the mediastinal lymph node (Blomgran and
Ernst, 2011), and that neutrophils contribute to the kinetics of
Th1 responses in mice infected with M. tuberculosis (Kang
et al., 2011). They also extend our previous findings that neutro-
phils facilitate activation of naive CD4 T cells by revealing thatCell HM. tuberculosis inhibits neutrophil apoptosis. By this mecha-
nism, M. tuberculosis apparently tempers the effects of neutro-
phils on CD4 T cell activation, as indicated by the finding that
depletion of neutrophils abrogates a major fraction of the
accelerated activation of CD4 T cells in mice infected with the
DnuoG mutant compared to that in mice infected with wild-
type H37Rv. The results presented here reveal that neutrophil
apoptosis is an important element of the interaction with den-
dritic cells in the lungs and indicate that enhancing neutrophil
apoptosis accelerates the onset of adaptive immunity in mice
infected with M. tuberculosis. Conversely, bacterial inhibition
of neutrophil apoptosis contributes to the delayed onset of
adaptive immunity in tuberculosis and provides additional time
for the expansion of the bacterial population before the onset
of immune control of the infection.
Although the studies reported here focused on neutrophil
apoptosis, neutrophils have been reported to play additional
roles during mycobacterial infections in vivo. For example,
neutrophils have been found to transport M. bovis BCG fromost & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier Inc. 87
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(Abadie et al., 2005). However, after aerosol infection with
virulent M. tuberculosis, we have not detected neutrophils in
the mediastinal lymph node examined at any time postinfection
(Blomgran and Ernst, 2011). In addition, neutrophils have
been reported to modulate lung inflammation after intranasal
administration of M. bovis BCG by synthesizing and secreting
interleukin-10 (Zhang et al., 2009). Thus, neutrophils have the
capacity for complex roles in the outcomes of infection that
extend beyond their well-characterized roles as phagocytes,
warranting further investigation.
The finding that depletion of neutrophils in mice infected with
either wild-type (Blomgran and Ernst, 2011) or the DnuoG
strain of M. tuberculosis results in delayed activation of naive
antigen-specific CD4 T cells suggests that neutrophils may
have a role in promoting activation of naive CD4 T cells in other
contexts. However, when we depleted neutrophils from mice
immunized with recombinant Ag85B in complete Freund’s adju-
vant, we observed no difference in the extent of proliferation of
CFSE-labeled P25TCR-Tg CD4 T cells in the local-draining
lymph node (data not shown). This suggests that the role of
neutrophils andmodulation of their apoptosis found in our exper-
iments with M. tuberculosis does not extend to immunization
with a purified protein antigen.
In summary, we have found that virulent M. tuberculosis
inhibits apoptosis of a broad range of phagocytic cells in the
lungs. This results in restricted cell-to-cell spread of the bacteria
at a specific stage of infection and contributes to the delayed
onset of adaptive immunity that characterizes murine (Chacker-
ian et al., 2002; Shafiani et al., 2010; Wolf et al., 2008) and
human (Poulsen, 1950; Wallgren, 1948) tuberculosis. In addition,
we found that inhibition of neutrophil apoptosis contributes to
the delayed activation of naive CD4 T cells in tuberculosis, indi-
cating that interactions between distinct types of phagocytic
cells are essential elements in development of protective immu-
nity in tuberculosis. These findings suggest that variations in the
molecular mediators of those interactions may contribute to the
differential outcomes of M. tuberculosis infection in humans.
They also suggest that tuberculosis vaccines that optimize
these interactions may have significantly greater efficacy than
the existing BCG vaccine.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were bred and housed in a specific pathogen-free environment
in New York University School of Medicine (New York, NY) animal facilities or
were purchased from The Jackson Laboratory (Bar Harbor, ME). P25TCR-Tg
mice, whose CD4 T cells express a transgenic T cell Ag receptor that recog-
nizes peptide 25 (aa 240–254) of M. tuberculosis Ag85B bound to I-Ab were
on a C57BL/6 background (CD45.2) as previously described (Bold et al.,
2011; Tamura et al., 2004; Wolf et al., 2008), and were bred in the New York
University School of Medicine animal facilities. CD45.1mice used as recipients
in transfer experiments were either bred in New York University School of
Medicine animal facilities or purchased from Taconic Farms, Inc. Genotypes
of mice were confirmed by PCR testing of tail genomic DNA. All animal
experiments were done in accordance with procedures approved by the
NYU School of Medicine Institutional Animal Care and Use Committee and
in strict accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health under the
Assurance of Compliance Number A3435-01.88 Cell Host & Microbe 11, 81–90, January 19, 2012 ª2012 Elsevier IAntibodies, FACS Staining, and Acquisition
All Abs were purchased from BD PharMingen unless otherwise stated. Anti-
CD11c PerCP (H3L) (1:200) was custom-conjugated from BD PharMingen.
Other Ab conjugates used were anti-CD45.2 PerCP (1:200), anti-CD4 Alexa
Fluor 647 (1:200), anti-CD69 PE (1:200), anti-CD11b PB (1:1500), anti-Ly6G
Alexa Fluor 647 (1:600), anti-Gr-1 APC, or Alexa Fluor 700 (1:1500). Staining
for surface markers was done by resuspending up to 1 3 106 cells in 100 ml
FACS-buffer (PBS supplementedwith 1%heat-inactivated fetal bovine serum,
0.1% NaN3 and 1 mM EDTA) containing Abs and incubated at 4
C for 25 min.
Cells were then washed twice and fixed overnight in PBS/1% paraformalde-
hyde at 4C. For intracellular staining, samples were first stained with surface
markers, washed twice, and treated with Cytofix/Cytoperm according to the
manufacturer’s instructions (BD PharMingen). Fixed and permeabilized
samples were stained with Alexa Fluor 647 rabbit anti-active caspase-3
(BD560626; 1:20) or Alexa Fluor 647 rabbit (DA1E) mAb isotype control (Cell
Signaling #2985; 1:200) diluted in Perm/Wash buffer at 4C for 30 min. Data
were acquired using FACS Calibur or LSR II flow cytometer depending on
the experiment.
P25TCR-Tg CD4+ T Cell Isolation and Labeling
P25TCR-Tg mice between 8–16 weeks of age were killed according to
approved laboratory animal procedures, and naive P25TCR-Tg CD4+ T cells
from lymph nodes and spleen were isolated as previously described (Wolf
et al., 2008). For proliferation assays, CD4+ T cells were labeled with CFSE
(CFDA-SE; Invitrogen).
Adoptive Transfer and Aerosol Infection
CD45.1 mice received 2-3 3 106 CFSE-labeled P25TCR-Tg CD4+ T cells
(CD45.2) by tail vein or retro-orbital injection, in 100 ml of sterile PBS. At
3–24 hr following cell transfer, mice were infected with the specified strains
of M. tuberculosis by the aerosol route, using an Inhalation Exposure Unit
(Glas-Col), and the infectious dose was confirmed by euthanizing 4–5 mice
after 24 hr of infection and plating lung homogenates as previously described
(Wolf et al., 2007).
Bacterial Strains, Tissue Processing and CFU Determination
GFP-expressing DnuoG M. tuberculosis and the parental H37Rv (GFP-nuoG)
were used to infect mice by aerosol as previously described (Wolf et al.,
2007). Mice were euthanized at designated time points, and tissues were
used to prepare single-cell suspensions and to determine the bacterial loads
by plating, as described (Wolf et al., 2008; Wolf et al., 2007).
Phenotyping and Quantitation of Lung Cells
For identification of lung macrophage and dendritic cell subsets, neutrophils
(Gr-1high/CD11bhigh) (Daley et al., 2008; Wolf et al., 2007) were gated out
and analyzed separately. Based on previous functional and morphological
characterization, the lung-cell subsets were designated as alveolar macro-
phages (CD11blow/CD11chigh), myeloid DC (CD11bhigh/CD11chigh), recruited
macrophages (CD11bhigh/CD11cintemediate), and monocytes (CD11bhigh/
CD11cnegative) (Gonzalez-Juarrero et al., 2003; Wolf et al., 2007).
Cell Sorting and Microscopy of Infected Cells
Single-cell suspensions of lung cells from mice infected with GFP-DnuoG,
GFP-H37Rv or unmarked H37Rv (used to determine settings for specific
detection of GFP) were surface stained with CD11b PB, CD11c PerCP, and
Ly6G as described above. The GFP+ cells within the different cell subsets
were sorted using a BD FACSAria Cell sorter, cytospun onto microscope
slides and dried over night. Slides were stained with DAPI and mounted with
VectaShield H-100 (Vector Laboratories, Inc. Burlingame, CA). The number
of bacteria per infected cell was scored using a Leica DMRB fluorescent
microscope (objective: Leica PL FLUOTAR 1003/1.30 oil). The identity of
the samples was blinded by a neutral observer, and 200–400 infected cells
per slide were counted.
In Vivo Neutrophil Depletion
The purified Ly6G-specific antibody 1A8 (Daley et al., 2008) was used to
deplete neutrophils in vivo; purified 2A3 (Rat IgG2a) was used as isotype
control antibody; both were obtained from BioXcell (West Lebanon, NH).nc.
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confounding effects of an immune response toward the depleting Ab (Seiler
et al., 2000). Administration of 1A8 had no effect on Ly6C+ cells in spleen or
lungs 2 days after administration, at which time neutrophils were depleted
by > 90% (data not shown).
Statistical Analysis
Unless otherwise indicated, statistical comparison was performed using an
unpaired, two-tailed Student’s t-test, using Prism 4 for Macintosh (version
4.0a) from GraphPad Software (GraphPad, San Diego, CA). p values:
*,p < 0.05 were considered significant, but **, p < 0.01 and ***, p < 0.001, are
also shown when appropriate.
SUPPLEMENTAL INFORMATION
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